Sleep Disorders: Insomnia, Restless Legs Syndrome (RLS) & Narcolepsy — clinical cases
30 questions
Sample cases
- Case 1
A 52-year-old man with chronic insomnia disorder has taken zolpidem nightly for 14 months. He still reports poor sleep and daytime fatigue, wants to keep his medication for now, and has never tried any behavioural treatment. According to the 2026 AASM guideline on combining CBT-I with medication, which recommendation is most appropriate?
- A.Continue zolpidem alone and increase the dose to improve sleep maintenance
- B.Add cognitive behavioural therapy for insomnia (CBT-I) rather than continuing zolpidem alone
- C.Add trazodone at bedtime to zolpidem to target sleep maintenance
- D.Replace zolpidem with diphenhydramine to avoid hypnotic dependence
- Case 2
A 31-year-old woman with a 5-month history of difficulty falling and staying asleep (3 nights per week, with daytime fatigue) was given a sleep hygiene handout 6 weeks ago (regular wake time, limit caffeine, avoid screens in bed). She followed it, but her sleep is unchanged. Which statement about her management is most consistent with the AASM guideline on behavioural treatments for chronic insomnia?
- A.Sleep hygiene education alone is not recommended; she should be offered multicomponent CBT-I
- B.Sleep hygiene education should be repeated for another 6 weeks before any other therapy
- C.Sleep hygiene failure means she should now start melatonin as the next standard step
- D.Sleep hygiene has failed, so behavioural approaches are exhausted and a hypnotic is required
- Case 3
A community pharmacist is reviewing evidence for agents that patients with chronic insomnia commonly request. According to the AASM clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults, which agents does the guideline suggest clinicians NOT use for sleep-onset or sleep-maintenance insomnia? Select ALL that apply.
- A.Diphenhydramine
- B.Low-dose doxepin
- C.Trazodone
- D.Suvorexant
- E.Melatonin
